Hemalkumar B Mehta
Biographic Data
| ID | 1210256 |
|---|---|
| NAME | Hemalkumar B Mehta |
| GIVEN NAMES | Hemalkumar B |
| FAMILY NAME | Mehta |
| SIGNATURE | MEHTA H B |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0001-9134-6370 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Hospital-Level Variation in Covid-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To characterize variation in dexamethasone and remdesivir use over time among hospitals. BACKGROUND: Little is known about hospital-level variation in COVID-19 drug treatments in a large and diverse network in the United States. METHODS: We selected individuals hospitalized with COVID-19 across 163 hospitals between February 23, 2020 and October 31, 2021 from using the HCA CHARGE, an electronic…
Racial and Ethnic Disparities in Cancer Mortality and Mediating Effects of Sociodemographic, Clinicopathologic, and Treatment Factors
The Intersections of Covid-19, HIV, and Race/Ethnicity: Machine Learning Methods to Identify and Model Risk Factors for Severe Covid-19 in a Large U.S. National Dataset
Risk factors associated with post-acute sequelae of Sars-CoV-2: An N3C and NIH Recover study
This national study identified important risk factors for PASC diagnosis such as middle age, severe COVID-19 disease, and specific comorbidities. Further clinical and epidemiological research is needed to better understand underlying mechanisms and the potential role of vaccines and therapeutics in altering PASC course
Comparative Performance of Diagnosis-based and Prescription-based Comorbidity Scores to Predict Health-related Quality of Life
OBJECTIVES: To compare the performance of the health-related quality of life-comorbidity index (HRQoL-CI) with the diagnosis-based Charlson, Elixhauser, and combined comorbidity scores and the prescription-based chronic disease score (CDS) in predicting HRQoL in Agency of Healthcare Research and Quality priority conditions (asthma, breast cancer, diabetes, and heart failure). METHODS: The Medical Expenditure Panel Survey (2005 and 2007-2011) data…
Comparison of Comorbidity Scores in Predicting Surgical Outcomes
The CMS-HCC had superior performance in predicting surgical outcomes. Prescription-based scores, alone or in addition to diagnosis-based scores, were not better than any diagnosis-based scoring system
No prominent works on this page.
Comparative Performance of Diagnosis-based and Prescription-based Comorbidity Scores to Predict Health-related Quality of Life
OBJECTIVES: To compare the performance of the health-related quality of life-comorbidity index (HRQoL-CI) with the diagnosis-based Charlson, Elixhauser, and combined comorbidity scores and the prescription-based chronic disease score (CDS) in predicting HRQoL in Agency of Healthcare Research and Quality priority conditions (asthma, breast cancer, diabetes, and heart failure). METHODS: The Medical Expenditure Panel Survey (2005 and 2007-2011) data…
Comparison of Comorbidity Scores in Predicting Surgical Outcomes
The CMS-HCC had superior performance in predicting surgical outcomes. Prescription-based scores, alone or in addition to diagnosis-based scores, were not better than any diagnosis-based scoring system
Risk factors associated with post-acute sequelae of Sars-CoV-2: An N3C and NIH Recover study
This national study identified important risk factors for PASC diagnosis such as middle age, severe COVID-19 disease, and specific comorbidities. Further clinical and epidemiological research is needed to better understand underlying mechanisms and the potential role of vaccines and therapeutics in altering PASC course
The Intersections of Covid-19, HIV, and Race/Ethnicity: Machine Learning Methods to Identify and Model Risk Factors for Severe Covid-19 in a Large U.S. National Dataset
Hospital-Level Variation in Covid-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To characterize variation in dexamethasone and remdesivir use over time among hospitals. BACKGROUND: Little is known about hospital-level variation in COVID-19 drug treatments in a large and diverse network in the United States. METHODS: We selected individuals hospitalized with COVID-19 across 163 hospitals between February 23, 2020 and October 31, 2021 from using the HCA CHARGE, an electronic…
Racial and Ethnic Disparities in Cancer Mortality and Mediating Effects of Sociodemographic, Clinicopathologic, and Treatment Factors
Internal Medicine (4 works) · Medicine (4 works) · COVID-19 Clinical Research Studies (3 works) · Demography (3 works) · Logistic regression (3 works) · Breast cancer (2 works) · Cancer (2 works) · Cohort (2 works) · Cohort study (2 works) · Comorbidity (2 works)